IN2012CH05549A - - Google Patents
Download PDFInfo
- Publication number
- IN2012CH05549A IN2012CH05549A IN5549CH2012A IN2012CH05549A IN 2012CH05549 A IN2012CH05549 A IN 2012CH05549A IN 5549CH2012 A IN5549CH2012 A IN 5549CH2012A IN 2012CH05549 A IN2012CH05549 A IN 2012CH05549A
- Authority
- IN
- India
- Prior art keywords
- composition
- ibuprofen
- pharmaceutically acceptable
- acceptable salt
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN5549CH2012 IN2012CH05549A (de) | 2012-12-31 | 2013-12-27 | |
PCT/IB2013/061370 WO2014102745A1 (en) | 2012-12-31 | 2013-12-27 | High drug load ibuprofen sustained release composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN5549CH2012 IN2012CH05549A (de) | 2012-12-31 | 2013-12-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012CH05549A true IN2012CH05549A (de) | 2015-07-03 |
Family
ID=51019974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN5549CH2012 IN2012CH05549A (de) | 2012-12-31 | 2013-12-27 |
Country Status (2)
Country | Link |
---|---|
IN (1) | IN2012CH05549A (de) |
WO (1) | WO2014102745A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201502077D0 (en) * | 2015-02-09 | 2015-03-25 | Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd | Improved hme technology |
WO2019072877A1 (en) * | 2017-10-10 | 2019-04-18 | Capsugel Belgium Nv | GETTING MULTIPARTICULAR COMPOSITIONS |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
US20080311162A1 (en) * | 2007-05-16 | 2008-12-18 | Olivia Darmuzey | Solid form |
-
2013
- 2013-12-27 IN IN5549CH2012 patent/IN2012CH05549A/en unknown
- 2013-12-27 WO PCT/IB2013/061370 patent/WO2014102745A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2014102745A1 (en) | 2014-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015120110A3 (en) | Novel pharmaceutical formulations | |
WO2015018380A3 (en) | Therapeutic nanoparticles and the preparation methods thereof | |
EP3626253A3 (de) | Stabile linaclotidformulierungen | |
MX2013014788A (es) | Liberacion modificada de 4-metil-3-[[4-(3-piridinl)-2-pirimidinil] -amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil ]-benzamida solubilizada utilizando acidos organicos. | |
MX2011007817A (es) | Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion. | |
PH12015501096A1 (en) | Composition for immediate and extended release | |
MY157673A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
PH12014502512A1 (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
TN2015000135A1 (en) | Modified release formulations for oprozomib | |
MX344846B (es) | Combinacion de granulos cargados activos con activos adicionales. | |
WO2012085284A3 (en) | High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts | |
MX2016001422A (es) | Composicion farmaceutica de fingolimod. | |
PH12016500865A1 (en) | Composite formulation comprising tadalafil and amlodipine | |
WO2014056824A3 (en) | Oral care composition | |
PH12015501377A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
WO2012085249A3 (en) | Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid | |
MX2014014579A (es) | Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide. | |
WO2014006636A3 (en) | Stable compositions of fesoterodine | |
EP2871187A4 (de) | Neuartige verbindung oder pharmazeutisch unbedenkliches salz davon und pharmazeutische zusammensetzung damit als wirkstoff | |
IN2012CH05549A (de) | ||
EP2722322A4 (de) | 1,3-di-oxo-inden-derivat, pharmazeutisch zulässiges salz und optisches isomer davon, herstellungsverfahren dafür und pharmazeutische zusammensetzung mit diesem derivat als antiviralem wirkstoff | |
WO2013072770A3 (en) | Pharmaceutical formulations comprising atorvastatin and glimepiride | |
EP2842938A4 (de) | Neuartige beta-alaninderivate, pharmazeutisch unbedenkliche salze davon sowie pharmazeutische zusammensetzung damit als wirkstoff | |
WO2011161223A3 (en) | Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts | |
WO2016126115A3 (en) | Pharmaceutical composition comprising pitavastatin or a pharmaceutically acceptable salt thereof, and valsartan or a pharmaceutically acceptable salt thereof |